Mitochondrial iron as a potential therapeutic target in friedreich's ataxia neurodegeneration: desferioxamine-peptide conjugate

被引：0
|
作者：
Pastrana Alta, Roxana Yesenia [1 ]
Machini, Maria Teresa [1 ]
Esposito, Breno Pannia [1 ]
机构：
[1] Univ Sao Paulo, Inst Quim, Lab Peptide Chem, BR-05508 Sao Paulo, Brazil
来源：
PROTEIN SCIENCE | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
PB-053
引用
收藏
页码：33 / 33
页数：1
相关论文
共 44 条
  • [21] Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for Parkinson's disease
    Xiao, Zhixin
    Wang, Xiaoya
    Pan, Xuening
    Xie, Junxia
    Xu, Huamin
    EXPERIMENTAL NEUROLOGY, 2024, 372
  • [22] HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich's Ataxia
    Sherzai, Mursal
    Valle, Adamo
    Perry, Nicholas
    Kalef-Ezra, Ester
    Al-Mahdawi, Sahar
    Pook, Mark
    Virmouni, Sara Anjomani
    FRONTIERS IN GENETICS, 2020, 11
  • [23] Possible role of heme iron for mitochondrial homeostasis in the heart of Friedreich's ataxia at early stage
    Kim, Yuho
    Dhorajia, Varun
    Cheng, Ruiying
    Kim, Jonghan
    PHYSIOLOGY, 2023, 38
  • [24] CCC1 suppresses mitochondrial damage in the yeast model of Friedreich's ataxia by limiting mitochondrial iron accumulation
    Chen, OS
    Kaplan, J
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) : 7626 - 7632
  • [25] Recombinant AAVs Target Custom Frataxin Therapeutic Cassettes to Tissues of Pathophysiologic Relevance in Friedreich's Ataxia
    Hori, Acacia
    Robinson, J. Elliott
    Chan, Ken
    Flytzanis, Nicholas
    Goeden, Nick
    Deverman, Ben
    Gradinaru, Viviana
    MOLECULAR THERAPY, 2020, 28 (04) : 86 - 87
  • [26] Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts - A decrease in antioxidative capacity?
    Sturm, B
    Bistrich, U
    Schranzhofer, M
    Sarsero, JP
    Rauen, U
    Scheiber-Mojdehkar, B
    de Groot, H
    Ioannou, P
    Petrat, F
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (08) : 6701 - 6708
  • [27] Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease
    Rai, Sachchida Nand
    Singh, Charan
    Singh, Arti
    Singh, M. P.
    Singh, Brijesh Kumar
    MOLECULAR NEUROBIOLOGY, 2020, 57 (07) : 3075 - 3088
  • [28] Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease
    Sachchida Nand Rai
    Charan Singh
    Arti Singh
    M. P. Singh
    Brijesh Kumar Singh
    Molecular Neurobiology, 2020, 57 : 3075 - 3088
  • [29] Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich's Ataxia
    Petrillo, Sara
    Piermarini, Emanuela
    Pastore, Anna
    Vasco, Gessica
    Schirinzi, Tommaso
    Carrozzo, Rosalba
    Bertini, Enrico
    Piemonte, Fiorella
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
  • [30] A caenorhabditis elegans model of Friedreich's ataxia shows iron sensitivity, mitochondrial DNA damage, and altered gene expression.
    Meyer, JN
    Boyd, WA
    Haugen, AC
    Freedman, JH
    Van Houten, B
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2004, 44 (03) : 215 - 215
12345